- Home
- ACET vs LSF Comparison
ACET vs LSF Comparison
Compare ACET & LSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACET | LSF |
|---|---|---|
| Founded | 1947 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.5M | 27.8M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | ACET | LSF |
|---|---|---|
| Price | $0.56 | $2.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $8.50 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 1.8M | 112.9K |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $48,146,862.00 |
| Revenue This Year | N/A | $18.05 |
| Revenue Next Year | N/A | $17.53 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 17.73 |
| 52 Week Low | $0.45 | $2.25 |
| 52 Week High | $1.13 | $10.90 |
Technical Indicators
Market Signals| Indicator | ACET | LSF |
|---|---|---|
| Relative Strength Index (RSI) | 35.71 | 26.30 |
| Support Level | $0.53 | $2.47 |
| Resistance Level | $0.70 | $2.78 |
| Average True Range (ATR) | 0.06 | 0.19 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 17.45 | 15.25 |
Price Performance
Historical ComparisonAbout ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
About LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.